Evidence map›Paper›PMID 17726578›Full record

ReviewCancer metastasis reviews2007

Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway.

Susumu Nakahara, Avraham Raz

Open access · greenAbstract readReview
In one paragraph

Review in Cancer metastasis reviews, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Colorectal Cancers and Immunotherapy.Cancer treatment and research · 2025
    Review
  6. Review
  7. Review
  8. Galectin-2 in Health and Diseases.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. How galectins have become multifunctional proteins.Histology and histopathology · 2020
    Review
  13. Article
  14. Article
  15. Design-functionality relationships for adhesion/growth-regulatory galectins.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Tumor cells interact with red blood cells via galectin-4 - a short report.Cellular oncology (Dordrecht, Netherlands) · 2017
    Article
  20. Primordial odontogenic tumor: An immunohistochemical profile.Medicina oral, patologia oral y cirugia bucal · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Susumu NakaharaTumor Progression and Metastasis Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
Avraham Raz
The Barbara Ann Karmanos Cancer Institute · US

Funding

The Role of Tumor Cell Surface Lectin in MetastasesR37CA046120 · NCI · WAYNE STATE UNIVERSITY · PI RAZ, AVRAHAM · 2007 to 2014
$3.0M
TUMOR CELL SURFACE LECTIN AND METASTASISR01CA046120 · NCI · WEIZMANN INSTITUTE OF SCIENCE · PI RAZ, AVRAHAM · 1987 to 2006
$2.0M
NCI NIH HHS R01 CA046120NCI NIH HHS R37 CA046120NCI NIH HHS R37 CA-46120
6 · The paper itself

Abstract

Galectin-3 (Gal-3), a member of the beta-galactoside-binding gene family, distributes inside and outside the cell and has pleiotropic biological functions such as cell growth, cell adhesion, cell-cell interaction, and mRNA processing in a specific situation. In particular, Gal-3 in the nucleus plays a pivotal role in the regulation of cancer-related gene expression, including cyclin D1, TTF-1 and MUC2, presumably associated with tumor progression. Therefore, to understand the mechanism of nuclear import of Gal-3 is very significant and might be developed to the new approach for the cancer treatment. In this review, we focus on the role of Gal-3 in the nucleus and the molecular mechanism of nuclear import pathways of Gal-3, providing the hints for the inhibition of Gal-3 function.

Indexed as

Gene Expression RegulationActive Transport, Cell NucleusAnimalsCell NucleusCyclin D1DNA-Binding ProteinsGalectin 3HumansMucin-2MucinsNeoplasmsPhosphorylationProtein TransportTranscription FactorsCyclin D1DNA-Binding ProteinsGalectin 3MUC2 protein, humanMucin-2MucinsTranscription FactorsTTF1 protein, human

Identifiers

PMID17726578
PMCPMC3613988
OpenAlexW2092685992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.